山东绿叶制药有限公司 Lvye
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval 2019-03-29 11:48
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field 2019-01-16 19:08
Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process 2018-12-31 08:00
Luye Pharma's Global Strategy For CNS-Focused Products Gathers Pace: Rotigotine Extended Release Microspheres Submitted to Japan's PMDA for Clinical Trial Approval 2018-12-12 13:53
Luye Pharma Further Bolsters Global CNS Portfolio with Approval to Start LY03010 U.S. Clinical Trials 2018-09-27 18:41
Luye Pharma's Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators 2018-09-07 12:22
Luye Pharma Releases its Financial Results for the First Half of 2018: Double-Digit Growth in Core Product Sales, Exceeded Expectations in Sales, R&D and M&As 2018-08-29 17:40
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China 2018-07-22 22:11
1 2 3